CEO Steve Couldwell resigns from Tissue Regenix due to illness

Writer, Stock Market Wire
Thursday, August 1, 2019 - 09:45

Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness.

The firm said John Samuel would resume the position of executive chairman until a full time CEO appointment was made while COO Gareth Jones would take up the position of interim- CEO.

Mike Barker would continue to support the executive team as interim finance director.

At 9:45am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 3.75p


Related content

Tissue Regenix expects to breach revenue loan covenant; in talks with lender

Regenerative medical devices company Tissue Regenix said it was in talks with loan provider MidCap Financial Trust after assessing that it would likely breach on...

Mon, 11/11/2019 - 08:21


Tissue Regenix posts first-half loss; sees better second half

Regenerative medical devices company Tissue Regenix posted a first-half loss but said it expected to post a better performance in the second half owing to...

Tue, 10/09/2019 - 15:02


Tissue Regenix appoints Mike Barker as permanent CFO

Regenerative medical devices company Tissue Regenix said it had appointed Mike Barker as its chief financial officer.

Barker had been assisting the company as interim...

Wed, 28/08/2019 - 07:49


Tissue Regenix signs 10-year lease on facility in US to ramp up processing capacity

Medical devices group Tissue Regenix signed a 10-year lease agreement on a facility to expand processing capacity at its manufacturing base in San Antonio, Texas....

Thu, 15/08/2019 - 08:46


Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31